SHARE

How Pfizer’s vaccine will affect stocks in your portfolio

Wow, what a week! Pfizer announces it has a vaccine almost set to go, and hasn’t the market reacted! Happily for our investors, The Montgomery Fund has already pivoted towards a post-pandemic world: we’ve cut cash to a record low and invested in some businesses beaten down by enforced lockdowns.

Pfizer’s announcement is the strongest signal yet that the unparalleled search for a vaccine to bring the pandemic to an end might succeed.  While the Pfizer vaccine is more difficult to produce and distribute than many others, Dr Anthony Fauci said: “The results are really quite good, I mean extraordinary.”

The speed with which progress has occurred has also broken every scientific speed record and this is partly due to the winter months in the northern hemisphere increasing the rate of infection and therefore the number of people upon which the vaccine can be tested.

Exclusive Content

Exclusive Content

This is exclusive content to subscribers on rogermontgomery.com. View the full article via your subscription or sign up for access.

Funds

View all funds